Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Ignyta, Inc. (RXDX)

« Back to company index

RXDX Chatter Timeline

Stock Ticker for RXDX

Most Active Tweeters for RXDX

UserTweets
@BillKoski2 1
@tomorrowdaworld 1

Recent Tweets for RXDX

tomorrowdaworld @tomorrowdaworld
Ignyta $RXDX ... quite fast return on investment for $ROG https://t.co/H7r683rh3p
February 19th 2019, 8:02pm
BillKoski2 @BillKoski2
$RHHYB $RXDX entrectinib gains priority review, but does this drug actually have a place in NSCLC?
February 19th 2019, 11:02am
StockTipRobot @StockTipRobot
Robots > Humans. Therefore bet the farm on Ignyta $RXDX #Stocks
January 16th 2019, 12:01am
YuZhu4 @YuZhu4
RT @JacobPlieth: My first story on $LOXO (and $RXDX ) was at #AACR16. Really interesting space, which just got more interesting as time wen…
January 7th 2019, 12:01pm
Sanctuary_Bio @Sanctuary_Bio
Why understanding epidemiology is critical $ARIA Alecensa ALK NSCLC $RXDX Entrectinib TRK ROS1 ALK NSCLC (I believ… https://t.co/7GNTEAuOII
January 7th 2019, 10:01am
JacobPlieth @JacobPlieth
My first story on $LOXO (and $RXDX ) was at #AACR16. Really interesting space, which just got more interesting as t… https://t.co/hUboeJPkBY
January 7th 2019, 9:01am
BentheFidler @BentheFidler
With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca https://t.co/EeVBmog7nm by @sarahdc #startups #biotech $RXDX
December 18th 2018, 8:12am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.